These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Brienza N, Malcangi V, Dalfino L, Trerotoli P, Guagliardi C, Bortone D, Faconda G, Ribezzi M, Ancona G, Bruno F, Fiore T. Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657 [Abstract] [Full Text] [Related]
3. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent. Samuels J, Finkel K, Gubert M, Johnson T, Shaw A. Ren Fail; 2005 Mar; 27(1):101-5. PubMed ID: 15717642 [Abstract] [Full Text] [Related]
6. [Fenoldopam and kidney function in a case of abdominal aortic pseudoaneurysm with supra-renal clamping in an emergency protocol]. Caporelli S, Loggi S, Zompanti V, Romano R, Carbonari L, Alò F, Antognini M, Pelaia P. Recenti Prog Med; 2003 Nov; 94(11):501-5. PubMed ID: 14679918 [Abstract] [Full Text] [Related]
11. Current literature questions the routine use of low-dose dopamine. Abay MC, Reyes JD, Everts K, Wisser J. AANA J; 2007 Feb; 75(1):57-63. PubMed ID: 17304785 [Abstract] [Full Text] [Related]
12. The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant, and hypertensive patients. Mathur VS. Rev Cardiovasc Med; 2003 Feb; 4 Suppl 1():S35-40. PubMed ID: 12556736 [Abstract] [Full Text] [Related]
14. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. Murphy MB, Murray C, Shorten GD. N Engl J Med; 2001 Nov 22; 345(21):1548-57. PubMed ID: 11794223 [No Abstract] [Full Text] [Related]
15. Fenoldopam in critically ill patients with early renal dysfunction. A crossover study. Cobas M, Paparcuri G, De La Pena M, Cudemus G, Barquist E, Varon A. Cardiovasc Ther; 2011 Aug 22; 29(4):280-4. PubMed ID: 20955210 [Abstract] [Full Text] [Related]